[ad_1]
The Ministry of Public Health reveals the CU mRNA vaccine comparable to Pfizer, beginning research in people from January next year.
On November 10, 2020, reporters reported on Pfizer Inc. of the United States and Biotech Germany revealed the success of the COVID-19 vaccine. More than 90 percent effective in preventing disease
Recently, Matichon reported that the Ministry of Public Health (Ministry of Public Health) had a press release on their progress. Regarding obtaining a vaccine against Coronavirus 2019 or COVID-19
Dr. Nakorn Premsri, director of the National Vaccine Institute, said this is good news because 1. This success is expected to use the vaccine in the short term. Currently, there are 11 human vaccine companies and test vaccines in stimulant form to protect against the same infection.
2. Pfizer’s vaccine assay is of the mRNA type, which is very promising. Since a vaccine with more than 50 percent protection against the disease is considered valid. But in Pfizer’s case, it’s 90% efficient and mRNA-like. Of which Thailand by Chulalongkorn University is in development, it is also mRNA, so it is considered the correct form, which Chulalongkorn has planned for human research in January 2021.
3. Is this vaccine safe? Due to the trials in total 43,000 volunteers and 38,000 vaccinated, tens of thousands of volunteers who have already received the vaccine. Considered safe.But to be more confident, they should continue to follow up with other volunteers.
4. After this, Pfizer had to have a follow-up follow-up. Then you will apply for registration with the US Food and Drug Administration (FDA), it should be the responsibility of the US FDA to register for use in emergencies or not. Or you need to request more information Because I still have to stick with it Protection performance Or can the immune system be lowered? Due to testing of Pfizer data over 2 months, it should be followed up. Over time, there may be events that diminish your landscape. Will the efficiency be reduced by 90% or will the number of needles be injected?
5. Pfizer announced that the vaccine is 90 percent effective, which could lead to the discovery of immunity. That is determined in the prevention of diseases, it is possible. That this matter should follow However, before Pfizer announced the effectiveness of the vaccine, it would be possible. There was a previous appointment to discuss with Thailand about the exchange of information. That will be discussed in mid-November. We will request information from Pfizer. Support also the political decisions of Thai and Pfizer
Dr. Suchada Jiumsiri, Director of the Vaccine Prevention Division, said that now the Department of Disease Control is in the process of prioritizing risk groups that need the COVID-19 vaccine. In case of having a vaccine That of course The first group to which it is exposed are the health professionals at risk. Other groups Pending That must contain data that includes the disease rate. Mortality index That will include information from foreign countries. All are expected to be clear by the end of December. It will then be presented to the National Vaccine Board for further consideration.
[ad_2]
